OreStocks

MustGrow Biologics Corp. press release

BioMedNewsBreaks - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Lab Test Results of Patented Biopesticide Achieve 100% Control of Root-Rot Disease

TSXV - TSX Venture Exchange · Canada

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, has announced successful test results of its patented mustard-derived biopesticide on_Aphanomyces euteiches_zoospores ("Aphanomyces"). The tests, conducted via an independent third-party facility, achieved 100% control of the root-rot disease _Aphanomyces_zoospores at economic application rates within 24 hours; Aphanomyces is a soil-borne disease that destroys key plant-based protein crops such as peas, lentils and legumes; current treatments are unable to control the disease. MustGrow next plans to test its proprietary biopesticide in larger-scale greenhouse and field settings. The company’s safe and effective organic biopesticide is plant based, using the mustard seed's natural defense mechanism to control diseases, pests and weeds. Aphanomyces is a water-mold pathogen that destroys peas, lentils and other legumes, which are often referred to as pulse crops. Studies indicate that at least $20 million of pulse crops are lost annually in Canada as a result of Aphanomyces; worldwide that figure reaches $100 million. "It is great to see MustGrow's mustard plant-based biopesticide continue to perform, particularly with 100% disease control measured at exceptionally low application rates,” said MustGrow COO Colin Bletsky. “The level of control of hard-to-kill diseases we continue to achieve combined with the beneficial properties of our product for soil health provide a great opportunity for improved yields for farmers and a more robust food supply. I am very hopeful that we can potentially provide a valuable crop-protection tool for pulse crop farmers."

To view the full press release, visit: https://ibn.fm/0f4CD

About MustGrow Biologics Corp.

MustGrow is a publicly traded, agriculture biotech company focused on providing natural, science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed's natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow's safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada's Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high-value crops, including fruits and vegetables. MustGrow has now concentrated a liquid format, TerraMG, that with regulatory approval could be applied through standard drip or spray equipment, improving functionality and performance features. The company has approximately 37 million basic common shares issued and outstanding. For more information about the company, please visitwww.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at http://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWireto reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW) San Francisco, California www.BioMedWire.com 415.949.5050 Office Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Earlier from MustGrow Biologics Corp.